Endor Technologies has invested years in medical research in dermatology to develop new technologies to promote healthy-looking skin.
Patented formulations with gold thioethylamino hyaluronic acid, a new ingredient, developed with spherical gold nanoparticles conjugated to hundreds of low molecular weight hyaluronic acid oligomers. This innovative formulation is specifically designed to enhance the skin’s natural ability to produce hyaluronic acid, collagen and elastin.
Mechanism of action:
CD44 is a cell receptor involved in endogenous hyaluronic acid, collagen and elastin production. To be properly
activated it’s necessary to act on several of CD44 receptors at the same time. This effect can only be achieved
by using a delivery system, otherwise ligands will get the cell asynchronously so the cell receptor will not be activated. The next image represent the technical strategy followed to develop the new active ingredient:
